These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cytomegalovirus disease with atypical presentation in a renal transplant patient: case report. Khosravi M; Nobakht A; Nikokar AR Exp Clin Transplant; 2006 Jun; 4(1):458-61. PubMed ID: 16827643 [TBL] [Abstract][Full Text] [Related]
4. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis. Reischig T; Jindra P; Hes O; Bouda M; Kormunda S; Treska V Transplantation; 2009 Feb; 87(3):436-44. PubMed ID: 19202451 [TBL] [Abstract][Full Text] [Related]
5. The use of sirolimus in ganciclovir-resistant cytomegalovirus infections in renal transplant recipients. Ozaki KS; Câmara NO; Nogueira E; Pereira MG; Granato C; Melaragno C; Camargo LF; Pacheco-Silva A Clin Transplant; 2007; 21(5):675-80. PubMed ID: 17845644 [TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus disease in renal transplant recipients: a single-center experience. Basri N; Abdullah KA; Shaheen FA Exp Clin Transplant; 2007 Jun; 5(1):601-3. PubMed ID: 17617050 [TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of cytomegalovirus infection in simultaneous pancreas-kidney transplant recipients without ganciclovir prophylaxis. Rayes N; Seehofer D; Kahl A; Kokott S; Pratschke J; Frei U; Neuhaus P Transpl Int; 2007 Nov; 20(11):974-81. PubMed ID: 17680782 [TBL] [Abstract][Full Text] [Related]
8. Predictive factors for cytomegalovirus reactivation in cytomegalovirus-seropositive kidney-transplant patients. Kamar N; Mengelle C; Esposito L; Guitard J; Mehrenberger M; Lavayssière L; Ribes D; Cointault O; Durand D; Izopet J; Rostaing L J Med Virol; 2008 Jun; 80(6):1012-7. PubMed ID: 18428146 [TBL] [Abstract][Full Text] [Related]
9. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome. Reddy AJ; Zaas AK; Hanson KE; Palmer SM J Heart Lung Transplant; 2007 Dec; 26(12):1286-92. PubMed ID: 18096480 [TBL] [Abstract][Full Text] [Related]
11. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients. Nogueira E; Ozaki KS; Tomiyama H; Granato CF; Camara NO; Pacheco-Silva A Int Immunopharmacol; 2006 Dec; 6(13-14):2031-7. PubMed ID: 17161359 [TBL] [Abstract][Full Text] [Related]
12. Successful outcome of ganciclovir-resistant cytomegalovirus infection in organ transplant recipients after conversion to mTOR inhibitors. Sabé N; González-Costello J; Rama I; Niubó J; Bodro M; Roca J; Cruzado JM; Manito N; Carratalà J Transpl Int; 2012 Jul; 25(7):e78-82. PubMed ID: 22574951 [TBL] [Abstract][Full Text] [Related]
13. Severe cytomegalovirus infection in a second kidney transplant recipient treated with ganciclovir, leflunomide, and immunoglobulins, with complications including seizures, acute HCV infection, drug-induced pancytopenia, diabetes, cholangitis, and multi-organ failure with fatal outcome: a case report. Miszewska-Szyszkowska D; Mikołajczyk N; Komuda-Leszek E; Wieczorek-Godlewska R; Świder R; Dęborska-Materkowska D; Szmidt J; Durlik M Ann Transplant; 2015 Mar; 20():169-74. PubMed ID: 25813912 [TBL] [Abstract][Full Text] [Related]
14. Late primary cytomegalovirus infection presenting with acute inflammatory demyelinating polyneuropathy in a heart transplant recipient: a case report and review of the literature. Hodowanec AC; Simon DM Transpl Infect Dis; 2012 Oct; 14(5):E116-20. PubMed ID: 22938143 [TBL] [Abstract][Full Text] [Related]
15. Acute esophageal necrosis (black esophagus) in the renal transplant recipient: manifestation of primary cytomegalovirus infection. Trappe R; Pohl H; Forberger A; Schindler R; Reinke P Transpl Infect Dis; 2007 Mar; 9(1):42-5. PubMed ID: 17313471 [TBL] [Abstract][Full Text] [Related]
16. Prognostic effect of lymphocyte subgroup CD4+ and CD8+ cells in peripheral blood in renal transplant patients with cytomegalovirus viremia. Chen JS; Li LS; Cheng DR; Ji SM; Sun QQ; Cheng Z; Wen JQ; Sha GZ; Liu ZH Transplant Proc; 2009 Jun; 41(5):1639-42. PubMed ID: 19545698 [TBL] [Abstract][Full Text] [Related]
17. CMV infection in post kidney transplant recipient. Abdelrahman M; Karkar A Saudi J Kidney Dis Transpl; 2009 May; 20(3):481-2. PubMed ID: 19414958 [No Abstract] [Full Text] [Related]
18. Cytomegalovirus infection with multiple colonic perforations in a renal transplant recipient. De Bartolomeis C; Collini A; Barni R; Ruggieri G; Bernini M; Carmellini M Transplant Proc; 2005; 37(6):2504-6. PubMed ID: 16182726 [TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus infection of the major duodenal papilla in a renal allograft recipient with severe biliary obstruction and acalculous cholecystitis. Riediger C; Beimler J; Weitz J; Zeier M; Sauer P Transpl Infect Dis; 2013 Aug; 15(4):E129-33. PubMed ID: 23790000 [TBL] [Abstract][Full Text] [Related]
20. Update and review: state-of-the-art management of cytomegalovirus infection and disease following thoracic organ transplantation. Snydman DR; Limaye AP; Potena L; Zamora MR Transplant Proc; 2011 Apr; 43(3 Suppl):S1-S17. PubMed ID: 21482317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]